32.7
NRX Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
25.8
FY23:
6.88
FY24:
3.30
FY25:
8.89
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0.02
FY23:
0.43
FY24:
0.35
FY25:
4.06
Total assets
Change from FY21 to FY25
millions USD
FY21:
32.7
FY22:
25.8
FY23:
7.32
FY24:
3.65
FY25:
13.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.9
FY22:
15.6
FY23:
19.0
FY24:
21.9
FY25:
28.6
(negative)
millions USD
FY21:
0
FY22:
2.82
FY23:
0
FY24:
5.01
FY25:
0.32
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.8
FY22:
7.41
FY23:
−11.7
FY24:
−23.2
FY25:
−15.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
32.7
FY22:
25.8
FY23:
7.32
FY24:
3.65
FY25:
13.0
All amounts in millions USD